Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method

References

• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, third edition: Approved Standard M27-A3. NCCLS, Villanova, PA, USA, 2008.
   Google Scholar
• Morace G, Amato G, Bistoni F, . Multicenter comparative evaluation of six commercial systems and the National Committee for Clinical Laboratory Standards M27-A broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol 2002;40:2953–2958.
   PubMed Web of Science ®Google Scholar
• Matar MJ, Ostrosky-Zeichner L, Pretznick VL, . Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother 2003;47:1647–1651.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Pfaller M, Messer SA, . Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. J Clin Microbiol 2004;42:718–721.
   PubMed Web of Science ®Google Scholar
• Bernal S, Aller AI, Chávez M, . Comparison of the Sensititre Yeast One colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species. Chemotherapy 2002;48:21–25.
   PubMedGoogle Scholar
• Pfaller MA, Jones RN, the Microbiology Resource Committee of the College of American Pathologists. Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists (CAP) Microbiology Surveys Program (2001–2003). Arch Pathol Lab Med 2006;130:767–778.
   PubMedGoogle Scholar
• Martín-Mazuelos E, Gutiérrez MJ, Aller AI, . A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp. J Antimicrob Chemother 1999;43:477–481.
   Google Scholar
• Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, . Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp. : a collaborative study. J Clin Microbiol 2005;43:4535–4540.
   Web of Science ®Google Scholar
• Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, . International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole and voriconazole. J Clin Microbiol 2005;43:3884–3889.
   PubMed Web of Science ®Google Scholar
• Martins MD, Lozano-Chiu M, Rex JH. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant Candida albicans in human immunodeficiency virus-infected patients. Clin Infect Dis 1998;27:1291–1294.
   PubMed Web of Science ®Google Scholar
• Aller AI, Claro R, Castro C, . Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994–1996 and 1997–2005. Chemotherapy 2007;53:300–305.
   PubMed Web of Science ®Google Scholar
• Barry AL, Pfaller MA, Brown SD, . Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol 2000;38:3457–3459.
   PubMed Web of Science ®Google Scholar
• Hazen KC, Howell SA. Candida, Cryptococcus, and other yeasts of medical importance. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, R. H. Yolken. Manual of Clinical Microbiology. Washington, DC: ASM Press, 2003; 1693–1711.
   Google Scholar
• Ghannoum MA, Ibrahim AS, Yfu, . Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol 1992;30:2881–2886.
   PubMed Web of Science ®Google Scholar
• Aller AI, Martín-Mazuelos E, Lozano F, . Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother 2000;44:1544–1548.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Boyken L, . In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp. : global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob Agents Chemother 2002;46:3518–3521.
   Google Scholar
• Pfaller MA, Boyken L, Messer SA, . Evaluation of the Etest method using Mueller-Hinton agar with glucose and methylene blue for determinig amphotericin B MICs for 4,936 clinical isolates of Candida species. J Clin Microbiol 2004;42:4977–4979.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Rex JH, . Correlation of MIC with outcome for Candida species against voriconazole: analysis and proposal for interpretative breakpoints. J Clin Microbiol 2006;44:819–826.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 2006;19:435–447.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Procop GW, . Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. J Clin Microbiol 2006;45:796–802.
   Google Scholar
• Pfaller MA, Diekema DJ, Procop GW, . Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine and voriconazole against Candida spp. J Clin Microbiol 2007;45:3522–3528.
   PubMed Web of Science ®Google Scholar
• Posteraro B, Martucci R, La Sorda M, . Reliability of the VITEK 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata. J Clin Microbiol 2009;47:1927–1930.
   PubMedGoogle Scholar
• Ostrosky-Zeichner L, Rex JH, Pfaller MA, . Rationale for reading fluconazole MICs at 24 Hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Antimicrob Agents Chemother 2008;52:4175–4177.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Boyken LB, Hollis RJ, . Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program. J Clin Microbiol 2008;46:3585–3590.
   PubMed Web of Science ®Google Scholar